Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Ferroptosis Study in SF3B1-mutant Myelodysplastic Syndromes (FerMDS)

NCT05924074 is registered in ClinicalTrials.gov with University Hospital, Bordeaux as lead sponsor.

NCT NCT05924074
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05924074 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Ferroptosis Study in SF3B1-mutant Myelodysplastic Syndromes (FerMDS)
Lead sponsor
University Hospital, Bordeaux
Phase
Not applicable
Overall status
Recruiting
Start date
February 21, 2025
Completion date
February 28, 2027
Enrollment
80 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

ferroptosis, myelodysplastic syndromes